-
1
-
-
0027724063
-
Acarbose: An update of its pharmacology and therapeutic use in diabetes mellitus
-
J. A. Balfour and D. McTravish, Acarbose: An update of its pharmacology and therapeutic use in diabetes mellitus, Drugs 46 (1993) 1025-1054.
-
(1993)
Drugs
, vol.46
, pp. 1025-1054
-
-
Balfour, J.A.1
McTravish, D.2
-
2
-
-
0030984692
-
Inhibition of glucose absorption in the rat jejunum: A novel alpha-D-glucosidase inhibitors
-
A. J. Hirsh, S. Y. Yao, J. D. Young and C. I. Cheeseman, Inhibition of glucose absorption in the rat jejunum: a novel alpha-D-glucosidase inhibitors, Gastroenterology 113 (1997) 205-211.
-
(1997)
Gastroenterology
, vol.113
, pp. 205-211
-
-
Hirsh, A.J.1
Yao, S.Y.2
Young, J.D.3
Cheeseman, C.I.4
-
3
-
-
0031747759
-
The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus
-
M. Hanefeld, The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus, J. Diabetes Complicat. 12 (1998) 228-237.
-
(1998)
J. Diabetes Complicat.
, vol.12
, pp. 228-237
-
-
Hanefeld, M.1
-
4
-
-
0031748116
-
European study on dose-response relationship of acarbose as a first-line drug in non-insulin dependent diabetes mellitus: Efficacy and safety of low and high doses
-
S. Fischer, M. Hanefeld, M. Spengler, K. Boehme and T. Temelkova-Kurktschiev, European study on dose-response relationship of acarbose as a first-line drug in non-insulin dependent diabetes mellitus: efficacy and safety of low and high doses, Acta Diabetol. 35 (1998) 34-40.
-
(1998)
Acta Diabetol.
, vol.35
, pp. 34-40
-
-
Fischer, S.1
Hanefeld, M.2
Spengler, M.3
Boehme, K.4
Temelkova-Kurktschiev, T.5
-
5
-
-
0024343686
-
14C-acarbose to rats, dog and man
-
14C-acarbose to rats, dog and man, Arzneimittel-Forsch. 39 (1989) 1254-1260.
-
(1989)
Arzneimittel-Forsch.
, vol.39
, pp. 1254-1260
-
-
Ahr, H.J.1
Boberg, M.2
Krause, H.P.3
Maul, W.4
Muller, F.O.5
Ploschke, H.J.6
Weber, H.7
Wunsche, C.8
-
6
-
-
0026437814
-
Safety profile of acarbose, an alpha glucosidase inhibitor
-
P. Hollander, Safety profile of acarbose, an alpha glucosidase inhibitor, Drugs 44 (Suppl. 2) (1992) 47-53.
-
(1992)
Drugs
, vol.44
, Issue.SUPPL. 2
, pp. 47-53
-
-
Hollander, P.1
-
7
-
-
0030918913
-
Potentially lethal ileus associated with acarbose treatment for NIDDM
-
M. Odawara, C. Bannai, T. Saitoh, Y. Kawakarni and K. Yamahita, Potentially lethal ileus associated with acarbose treatment for NIDDM, Diabetes Care 20 (1997) 1210-1211.
-
(1997)
Diabetes Care
, vol.20
, pp. 1210-1211
-
-
Odawara, M.1
Bannai, C.2
Saitoh, T.3
Kawakarni, Y.4
Yamahita, K.5
-
8
-
-
0031785069
-
Acarbose-associated hepatotoxicity
-
R. J. Andrade, M. Lucena, J. L. Vega, M. Torres, F. J. Salmeron, V. Bellot, M. D. Garcia-Escano and P. Moreno, Acarbose-associated hepatotoxicity, Diabetes Care 21 (1998) 2029-2030.
-
(1998)
Diabetes Care
, vol.21
, pp. 2029-2030
-
-
Andrade, R.J.1
Lucena, M.2
Vega, J.L.3
Torres, M.4
Salmeron, F.J.5
Bellot, V.6
Garcia-Escano, M.D.7
Moreno, P.8
-
9
-
-
0033943387
-
Acarbose-induced acute hepatitis. Report of two events in the same patient
-
J. De La Vega, M. Crepso, J. M. Escudero, L. Sanchez and L. L. Rivas, Acarbose-induced acute hepatitis. Report of two events in the same patient, Gastroenterol. Hepatol. 23 (2000) 282-284.
-
(2000)
Gastroenterol. Hepatol.
, vol.23
, pp. 282-284
-
-
De La Vega, J.1
Crepso, M.2
Escudero, J.M.3
Sanchez, L.4
Rivas, L.L.5
-
10
-
-
0025289809
-
Isolation and structural elucidation of biotransformation products from acarbose
-
M. Boberg, J. Kurz, H. J. Ploschke, P. Schmitt, H. Scholl, M. Schuller and C. Wunsche, Isolation and structural elucidation of biotransformation products from acarbose, Arzneimittel-Forsch. 40 (1990) 555-563.
-
(1990)
Arzneimittel-Forsch.
, vol.40
, pp. 555-563
-
-
Boberg, M.1
Kurz, J.2
Ploschke, H.J.3
Schmitt, P.4
Scholl, H.5
Schuller, M.6
Wunsche, C.7
-
11
-
-
0036251569
-
Hepatotoxicity of commonly used drugs: Nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs
-
S. Chitturi and J. George, Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs, Semin. Liver Dis. 22 (2002) 169-183.
-
(2002)
Semin. Liver Dis.
, vol.22
, pp. 169-183
-
-
Chitturi, S.1
George, J.2
-
12
-
-
0043071285
-
Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice
-
D. Juretić, Š. Bernik, Lj. Čop, M. Hadžija, R. Petlevski and J. Lukač-Bajalo, Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice, J. Anim. Physiol. Anim. Nutr. 87 (2003) 263-268.
-
(2003)
J. Anim. Physiol. Anim. Nutr.
, vol.87
, pp. 263-268
-
-
Juretić, D.1
Bernik, Š.2
Čop, L.3
Hadžija, M.4
Petlevski, R.5
Lukač-Bajalo, J.6
-
13
-
-
71849104860
-
Protein measurement with the Folin phenol reagens
-
O. H. Lowry, N. Rosebrough, A. L. Farr and R. J. Randall, Protein measurement with the Folin phenol reagens, J. Biol. Chem. 193 (1951) 265-270.
-
(1951)
J. Biol. Chem.
, vol.193
, pp. 265-270
-
-
Lowry, O.H.1
Rosebrough, N.2
Farr, A.L.3
Randall, R.J.4
-
14
-
-
0038242286
-
The effects of acarbose and Rumex patientia on liver ultrastructure in streptozotocin-induced diabetic (type II) rats
-
I. Degirmenchi, S. Kalender, M. C. Ustuner, Y. Kalender, H. V. Gunes, N. Unal and A. Basaran, The effects of acarbose and Rumex patientia on liver ultrastructure in streptozotocin-induced diabetic (type II) rats, Drugs Exp. Clin. Res. 28 (2002) 229-234.
-
(2002)
Drugs Exp. Clin. Res.
, vol.28
, pp. 229-234
-
-
Degirmenchi, I.1
Kalender, S.2
Ustuner, M.C.3
Kalender, Y.4
Gunes, H.V.5
Unal, N.6
Basaran, A.7
-
15
-
-
0025844038
-
Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivate emiglitate (BAYo 1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II)
-
B. Lembcke, R. Lamberts, J. Wohler and W. Creutzfeldt, Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivate emiglitate (BAYo 1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II), Res. Exp. Med. 191 (1991) 389-404.
-
(1991)
Res. Exp. Med.
, vol.191
, pp. 389-404
-
-
Lembcke, B.1
Lamberts, R.2
Wohler, J.3
Creutzfeldt, W.4
-
17
-
-
0036251953
-
Effect of acarbose on glucose-6-phosphatase in liver of CBA diabetic mice
-
R. Petlevski, D. Juretić, Lj. Mayer, M. Hadžija, M. Slijepčević and J. Lukač-Bajalo, Effect of acarbose on glucose-6-phosphatase in liver of CBA diabetic mice, Period. Biol. 104 (2002) 73-75.
-
(2002)
Period. Biol.
, vol.104
, pp. 73-75
-
-
Petlevski, R.1
Juretić, D.2
Mayer, L.3
Hadžija, M.4
Slijepčević, M.5
Lukač-Bajalo, J.6
-
18
-
-
0034839569
-
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis
-
J. Radziuk and S. Pye, Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis, Diabetes Metab. Res. Rev. 17 (2001) 250-272.
-
(2001)
Diabetes Metab. Res. Rev.
, vol.17
, pp. 250-272
-
-
Radziuk, J.1
Pye, S.2
|